Jing Zhang

机构：Guangzhou University of Chinese Medicine, Guangdong Pharmaceutical University · ORCID：0009-0004-9226-6523

发表论文 8 篇 · 总被引 265 次 · h-index 5

代表论文

• Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer (2024 · Molecular Cancer · 被引 110)
• Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway (2024 · Phytomedicine · 被引 87)
• Vitexin Protects against Dextran Sodium Sulfate-Induced Colitis in Mice and Its Potential Mechanisms (2022 · Journal of Agricultural and Food Chemistry · 被引 45)
• Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB (2020 · European Journal of Medicinal Chemistry · 被引 10)
• An Overview of Pre-expanded Perforator Flaps (2016 · Clinics in Plastic Surgery · 被引 10)
• Nystose mitigates mono sodium iodoacetate-induced knee osteoarthritis by inhibiting the NLRP3 Inflammasome (2025 · Phytomedicine · 被引 2)